TheraRadar
← Back
Data updated: Mar 29, 2026

ALEMBIC PHARMS LTD

CardiovascularNeurologyRespiratory
Generics

ALEMBIC PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Respiratory. Key products include DESVENLAFAXINE.

2009
Since
21
Drugs
-
Trials
227
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 57%
4 drugs
Neurology 14%
1 drugs
Respiratory 14%
1 drugs
Gastroenterology 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GE HEALTHCARE specialty
Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Cardiovascular, Gastroenterology, Respiratory
LEDERLE big-pharma
Cardiovascular, Neurology, Respiratory
Novartis big-pharma
Cardiovascular, Respiratory
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology